Veracyte, Inc. (VCYT)
44.36
-0.25
(-0.56%)
USD |
NASDAQ |
Dec 08, 16:00
44.36
0.00 (0.00%)
Pre-Market: 09:28
Veracyte Market Cap: 3.507B for Dec. 8, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| FONAR Corp. | 90.16M |
| XWELL, Inc. | 4.556M |
| ProPhase Labs, Inc. | 6.373M |
| Insight Molecular Diagnostics, Inc. | 141.60M |
| Exagen, Inc. | 158.42M |
Market Cap Related Metrics
| PE Ratio | 116.86 |
| PS Ratio | 7.124 |
| Price to Book Value | 2.788 |
| Price to Free Cash Flow | 35.91 |
| Price | 44.36 |
| Earnings Yield | 0.86% |
| Operating PE Ratio | 71.36 |
| Normalized PE Ratio | 75.17 |